Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00461552 · ClinicalTrials.gov registry record · Phase 2
Therapeutic Approaches to HAART-Induced Lipodystrophy
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
NCT00461552 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 23 participants.
The verdict
NCT00461552, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
Study Summary
To determine the efficacy and safety of 4 therapeutic interventions on HAART-Induced lipodystrophy. The interventions are: 1) Dietary - the effect of a high carbohydrate vs.a high cis-monounsaturated fatty acid diet. 2) The effect of aerobic exercise with dietary advice. 3) The effect of Omega-3 Fish Oil Capsules. 4) The effect of leptin therapy. These interventions are aimed at improving the metabolic complications of HAART therapy such as elevated lipids, and insulin resistance or diabetes.
Interventions
- OTHER Placebo
- DRUG Leptin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2003-01 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00461552
The ClinicalTrials.gov registry entry for NCT00461552 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00461552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00461552 about?
NCT00461552 is a clinical study titled "Therapeutic Approaches to HAART-Induced Lipodystrophy". To determine the efficacy and safety of 4 therapeutic interventions on HAART-Induced lipodystrophy. The interventions are: 1) Dietary - the effect of a high carbohydrate vs.a high cis-monounsaturated fatty acid diet. 2) The effect of aerobic exercise with dietary advice. 3) The effect of Omega-3 Fis...
What is the current status of trial NCT00461552?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2003-01. Estimated completion is 2014-09.
What interventions are being tested in trial NCT00461552?
The interventions under investigation include: Placebo (OTHER), Leptin (DRUG).
Who is sponsoring clinical trial NCT00461552?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.